NANOG and sarcoma: Here we examined three common sarcoma subtypes(fibrosarcoma, leiomyosarcoma, and liposarcoma) and found similar effects whentargeting Nanog and PI3K/Akt signaling in spheroid-forming cells andCD133(+) cells from these cell lines.